Otsuka Holdings Co., Ltd.
General ticker "OTSKF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $27.1B (TTM average)
Otsuka Holdings Co., Ltd. follows the US Stock Market performance with the rate: 19.8%.
Estimated limits based on current volatility of 0.0%: low 58.42$, high 58.42$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-30, amount 0.48$ (Y0.82%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [50.77$, 71.71$]
- 2025-12-31 to 2026-12-31 estimated range: [54.52$, 76.75$]
Financial Metrics affecting the OTSKF estimates:
- Negative: with PPE of 13.8 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 13.89
- Positive: 6.82 < Operating cash flow per share per price, % of 7.32
- Positive: Industry inventory ratio change (median), % of -0.66 <= -0.15
- Positive: -14.38 < Investing cash flow per share per price, % of -5.49
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.40 > 6.04
- Positive: Interest expense per share per price, % of 0.18 <= 0.79
- Positive: Shareholder equity ratio, % of 73.11 > 63.39
- Positive: 5.52 < Industry operating cash flow per share per price (median), % of 8.11
Short-term OTSKF quotes
Long-term OTSKF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | ¥1,737,998.00MM | ¥2,018,568.00MM | ¥2,329,861.00MM |
| Operating Expenses | ¥1,587,675.00MM | ¥1,878,956.00MM | ¥2,006,297.00MM |
| Operating Income | ¥150,323.00MM | ¥139,612.00MM | ¥323,564.00MM |
| Non-Operating Income | ¥22,631.00MM | ¥3,043.00MM | ¥12,290.00MM |
| Interest Expense | ¥6,063.00MM | ¥6,523.00MM | ¥8,791.00MM |
| R&D Expense | ¥275,230.00MM | ¥307,804.00MM | ¥314,233.00MM |
| Income(Loss) | ¥172,954.00MM | ¥142,655.00MM | ¥335,854.00MM |
| Taxes | ¥35,534.00MM | ¥17,155.00MM | ¥-11,417.00MM |
| Profit(Loss)* | ¥133,906.00MM | ¥121,616.00MM | ¥343,120.00MM |
| Stockholders Equity | ¥2,225,407.00MM | ¥2,393,683.00MM | ¥2,733,580.00MM |
| Inventory | ¥223,507.00MM | ¥249,581.00MM | ¥298,292.00MM |
| Assets | ¥3,102,716.00MM | ¥3,361,244.00MM | ¥3,739,251.00MM |
| Operating Cash Flow | ¥211,848.00MM | ¥283,232.00MM | ¥354,638.00MM |
| Capital expenditure | ¥107,787.00MM | ¥114,673.00MM | ¥129,362.00MM |
| Investing Cash Flow | ¥-81,575.00MM | ¥-190,538.00MM | ¥-265,793.00MM |
| Financing Cash Flow | ¥-95,474.00MM | ¥-60,168.00MM | ¥-189,367.00MM |
| Earnings Per Share** | ¥246.81 | ¥224.10 | ¥633.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.